Chlamydia conjunctivitis: Difference between revisions
| Line 1: | Line 1: | ||
==Background== | ==Background== | ||
* | *Caused by [[Chlamydia]] | ||
===Types=== | |||
*Trachoma | |||
**Serotypes A through C | |||
**Chronic [[keratoconjunctivitis]] | |||
**Most common form of preventable blindness in the world | |||
*Inclusion conjunctivitis | |||
**Serotypes D through K | |||
**Common, primarily sexually transmitted disease | |||
**Affects both newborns and adults | |||
==Clinical Features== | ==Clinical Features== | ||
Revision as of 19:01, 26 September 2020
Background
- Caused by Chlamydia
Types
- Trachoma
- Serotypes A through C
- Chronic keratoconjunctivitis
- Most common form of preventable blindness in the world
- Inclusion conjunctivitis
- Serotypes D through K
- Common, primarily sexually transmitted disease
- Affects both newborns and adults
Clinical Features
Newborns
- Tearing
- Conjunctival inflammation
- Eyelid swelling
- Moderate discharge
- Starting 5-12 days after birth
Adults
- Infection can be subacute or chronic
- Most common in young, sexually active persons aged 18 to 30 years
- Unilateral or bilateral redness
- Foreign body sensation
- Mucopurulent discharge
- Pre-auricular adenopathy
Differential Diagnosis
Conjunctivitis Types
Evaluation
Management
Adult
- Systemic antibiotics
- Azithromycin 1g PO x1
- Topical antibiotics
- Topical erythromycin ointment BID-TID x2-3 weeks
- Consider ceftriaxone for empiric gonorrhea coverage
Neonatal
Inclusion conjunctivitis
- Systemic antibiotics
- Erythromycin elixir 50mg/kg/d divided QID
- Topical antibiotics
- Erythromycin ointment QID
- Consultation with ophthalmology
- Special cultures may be required
Disposition
- Discharge with ophtho follow-up.